Regencell Bioscience Holdings Ltd
(RGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2006 | 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Sales | 2,598,100 | 2,516,700 | 2,468,000 | 2,489,900 | 2,140,200 |
| Cost of Goods | 1,011,400 | 983,100 | 973,400 | 1,001,800 | 874,700 |
| Gross Profit | 1,586,700 | 1,533,600 | 1,494,600 | 1,488,100 | 1,265,500 |
| Operating Expenses | 1,278,600 | 1,264,100 | 1,173,900 | 1,109,800 | 982,600 |
| Operating Income | 308,500 | 269,600 | 321,100 | 379,100 | 283,600 |
| Interest Expense | 125,200 | 117,300 | 95,600 | 72,000 | 61,700 |
| Other Income | -39,300 | 200 | -83,500 | -500 | -14,900 |
| Pre-tax Income | 144,000 | 152,500 | 142,000 | 306,600 | 207,000 |
| Income Tax | 57,700 | 60,700 | 59,500 | 121,200 | 89,800 |
| Net Income Continuous | 86,300 | 91,800 | 82,500 | 185,400 | 117,200 |
| Net Income | $86,300 | $91,800 | $82,500 | $185,400 | $117,200 |
| EPS Basic Total Ops | 0.58 | 0.63 | 0.57 | 1.34 | 0.83 |
| EPS Basic Continuous Ops | 0.58 | 0.63 | 0.57 | 1.34 | 1.09 |
| EPS Diluted Total Ops | 0.56 | 0.59 | 0.55 | 1.30 | 0.79 |
| EPS Diluted Continuous Ops | 0.56 | 0.59 | 0.55 | 1.30 | 1.04 |
| EBITDA(a) | $505,600 | $468,900 | $495,700 | $542,900 | $420,800 |